| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |